Avant Immunotherapeutics clinical trials
Acquired by Celldex Therapeutics, Mar 7, 2008 · source ↗
The registry lists 2 studies whose lead sponsor is Avant Immunotherapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 2, 2008.
Before and after it joined Celldex Therapeutics
- First submitted before Avant Immunotherapeutics became part of Celldex Therapeutics
- 2
- First submitted after Avant Immunotherapeutics became part of Celldex Therapeutics
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Avant Immunotherapeutics2 studies
Something wrong with this grouping? Tell us on the Celldex Therapeutics page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Celldex Therapeutics studies →
- Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult SubjectsCompletedNCT00498654Phase 2
Sponsor listed in the registry: Avant Immunotherapeutics · First submitted before Avant Immunotherapeutics became part of Celldex Therapeutics
- Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass SurgeryCompletedNCT00082121Phase 2
Sponsor listed in the registry: Avant Immunotherapeutics · First submitted before Avant Immunotherapeutics became part of Celldex Therapeutics